SHARLENE MARY DAY, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301065534
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301065534
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
1500 Floor Cardiovascular Ctr, Ann Arbor, MI 48109
Phone
(888) 287-1082
(734) 936-2047
(734) 936-2047
Personal information
See more information about SHARLENE MARY DAY at radaris.comName
Address
Phone
39509 Cather St, Canton, MI 48187
3905 N Michael Rd, Ann Arbor, MI 48103
3905 Michael Rd, Ann Arbor, MI 48103
Professional information
See more information about SHARLENE MARY DAY at trustoria.com
Dr. Sharlene M Day, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Sharlene M Day, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
1500 E Medical Center Dr SUITE 3, Ann Arbor 48109
(734) 647-7321 (Phone), (734) 936-7392 (Fax)
LIVONIA HEALTH CENTER
20321 Farmington Rd, Livonia 48152
(248) 888-9000 (Phone), (248) 888-9010 (Fax)
(734) 647-7321 (Phone), (734) 936-7392 (Fax)
LIVONIA HEALTH CENTER
20321 Farmington Rd, Livonia 48152
(248) 888-9000 (Phone), (248) 888-9010 (Fax)
Procedures:
Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest, Cardiac Myocardial Perfusion Imaging, Cardioversion, Elective, Coronary Angioplasty, Atherectomy and Stent, Peripheral Artery Catheterization, Thoracentesis
Conditions:
Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Endocarditis, Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart and Chronic Kidney Disease, Hypotension, Lipidoses (incl. Gaucher Disease), Mitral Valve Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Septal Defect, Syncope
Certifications:
Cardiovascular Disease, 2012, Internal Medicine, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr SUITE 3, Ann Arbor 48109
LIVONIA HEALTH CENTER
20321 Farmington Rd, Livonia 48152
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
LIVONIA HEALTH CENTER
20321 Farmington Rd, Livonia 48152
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
New York University
Graduated: 1995
University Of Michigan Hospitals
New York University
Graduated: 1995
University Of Michigan Hospitals
Sharlene Mary Day, Ann Arbor MI
Sharlene Mary Day, Ann Arbor MI
Specialties:
Cardiologist
Address:
1150 W Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
New York University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)
Compositions And Methods For Regulating Cardiac Performance
Compositions And Methods For Regulating Cardiac Performance
US Patent:
2008026, Oct 23, 2008
Filed:
Dec 1, 2005
Appl. No.:
11/792216
Inventors:
Joseph Metzger - Ann Arbor MI, US
Margaret Westfall - Ann Arbor MI, US
Sharlene Day - Ann Arbor MI, US
Margaret Westfall - Ann Arbor MI, US
Sharlene Day - Ann Arbor MI, US
International Classification:
A01K 67/027, C07H 21/04, C12N 15/63, C12N 15/87, C12N 5/10
US Classification:
800 21, 536 235, 4353201, 435440, 435354
Abstract:
The present invention relates to cardiac performance, in particular to regulating cardiac performance via recombinant troponin I (TnI) protein and nucleic acids encoding recombinant TnI. The present invention provides nucleic acids encoding gain of function TnI proteins (e.g., cTnlA164H), vectors containing such nucleic acids, host cells containing such vectors, transgenic animals carrying a gain of function TnI protein (e.g., a cTnlA164H transgene), and therapeutic agents (e.g., comprising recombinant TnI, TnI analogues, synthetic TnI, or the like) or agents for gene therapy of heart failure or disease for research and therapeutic uses.